HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Russell K Hales Selected Research

Lung Neoplasms (Lung Cancer)

1/2023DAART: a deep learning platform for deeply accelerated adaptive radiation therapy for lung cancer.
1/2021Improving Early Identification of Significant Weight Loss Using Clinical Decision Support System in Lung Cancer Radiation Therapy.
11/2020Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction Nomogram.
11/2020Imaging in Therapy Response Assessment and Surveillance of Lung Cancer: Evidenced-based Review With Focus on the Utility of 18F-FDG PET/CT.
10/2020Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapy.
4/2020Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact.
1/2020Multi-view radiomics and dosiomics analysis with machine learning for predicting acute-phase weight loss in lung cancer patients treated with radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Russell K Hales Research Topics

Disease

18Neoplasms (Cancer)
03/2024 - 10/2011
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 05/2013
7Lung Neoplasms (Lung Cancer)
01/2023 - 01/2020
6Pneumonia (Pneumonitis)
10/2021 - 10/2017
5Neoplasm Metastasis (Metastasis)
01/2023 - 11/2013
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2018 - 01/2017
3Weight Loss (Weight Reduction)
01/2021 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
07/2013 - 04/2013
1Frailty
04/2020
1Memory Disorders (Memory Loss)
11/2017
1Brain Neoplasms (Brain Tumor)
01/2017
1Oncogene Addiction
04/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2013
1Pituitary Neoplasms (Pituitary Adenoma)
10/2011
1Astrocytoma (Pilocytic Astrocytoma)
08/2010

Drug/Important Bio-Agent (IBA)

5Immune Checkpoint InhibitorsIBA
03/2024 - 12/2018
3B7-H1 AntigenIBA
10/2021 - 12/2018
1Programmed Cell Death 1 ReceptorIBA
03/2024
1relatlimabIBA
03/2024
1NivolumabIBA
03/2024
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2023
1durvalumabIBA
11/2022
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2020
1Fluorine-18IBA
11/2020
1AlbuminsIBA
04/2020
1Hemoglobins (Hemoglobin)IBA
04/2020
1CreatinineIBA
04/2020
1Basic Helix-Loop-Helix Transcription FactorsIBA
11/2013
1geldanamycinIBA
04/2013
1Molecular Chaperones (Chaperone, Molecular)IBA
04/2013
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
04/2013
1Androgen Receptors (Androgen Receptor)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013
1Sorafenib (BAY 43-9006)FDA Link
01/2013
1Nelfinavir (Viracept)FDA Link
10/2011
1HIV Protease InhibitorsIBA
10/2011

Therapy/Procedure

16Radiotherapy
03/2023 - 08/2010
11Therapeutics
01/2021 - 10/2011
7Immunotherapy
03/2024 - 12/2018
3Drug Therapy (Chemotherapy)
10/2020 - 01/2017
3Cranial Irradiation
11/2017 - 01/2017
2Chemoradiotherapy
03/2024 - 01/2017
1Drug Tapering
11/2019
1Combined Modality Therapy
10/2018